Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.
Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.
Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.
If left untreated, TTTS can have devastating consequences. Medical research indicates that:
TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.
Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.
Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.
Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:
Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.
Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.
Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.
According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.
When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.
Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.
Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."
Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.
Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.
The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.
Credit: Canva/Instagram
A young Internal Medicine doctor from Chandigarh has highlighted shocking malpractices followed by a well-known private hospital.
In a widely shared video posted on social media platform Instagram, Dr Prabhleen Kaur alleged that all patients arriving at the hospital in the city are being forcibly kept in Intensive Care Units (ICUs) even when it is not required.
The doctor had joined the hospital, as it was paying well and was near her clinic. However, seeing the blatant scam, she resigned in just one day.
Also Read: Scientists Link Vaping to 2 Types of Cancer; DNA-Damaging Chemicals to Blame
“I joined a very reputed hospital. I thought I would work there in the mornings and run OPD at my own clinic in the evenings. They were paying really well, no doubt about that,” the doctor said in the video.
The doctor alleged that the hospital “just needed a physician for the show”, while the entire handling of patients was being done by the owner, a gynecologist.
“But on my very first day, I realised that they only needed a physician in name. The hospital owner, who was a gynaecologist and not a physician, was managing all the patients herself. That means she would decide every patient should be admitted, and she would also decide that every admitted patient should be kept in the ICU – and kept there for as many days as possible,” Kaur said.
She further claimed that the goal at the said hospital was to make the patients remain admitted in the ICU for as long as possible. Kaur added she was deeply disturbed seeing this and refused to be part of a system that “harms patients for money.”
“It would have been my name, but their wrongdoing. So I resigned, because I cannot allow someone to use me as a front for unethical practices,” she said.
The doctor did not mention the name of the hospital. And HealthandMe could not independently verify the details and the authenticity of the post.
However, the incident reignites concerns over accountability, patient safety, and standards of care in the country.
The video went viral and the netizens found it concerning, and some also pointed out that such issues are common with many hospitals across the country.
"Unfortunately, most doctors are doing this unethical practice these days,” a user said.
“No surprise— the moment you enter a hospital, the first question is about insurance coverage. Feels like treatment comes second and billing comes first,” added another.
Some also lauded the doctor for resigning and sounding the alarm.
“Salute to your integrity. Rest of the Indians are just after making money,” said a user, while another noted: “Respect to this doctor for choosing her conscience over money".
Also read: NASA’s Artemis II Mission To Test Human Health in Deep Space
This is not the first such incident of hospital malpractice in the country.
Days earlier, a doctor from Assam called out private hospitals for overcharging patients with inflated medicine prices and unnecessary lab tests.
Dr Priyam Bordoloi said that corporate hospital chains rely on “predatory” practices and become a “financial sinkhole” for patients.
Earlier in January this year, a viral video with allegations of gross medical negligence and institutional apathy at Dhubri Medical College and Hospital (DMCH) sparked public outrage.
The video showed a family accusing hospital staff of failing to provide basic care, delaying critical dialysis treatment, and obstructing an emergency transfer.
The incident involved a 74-year-old Fulchand Chowdhury, whose condition reportedly worsened due to lapses in ICU monitoring, sanitation, and patient safety.
The family claimed they were forced to care for him themselves and faced resistance when seeking transfer to a private facility.
Also read: Bob Harris: BBC Radio 2 Host Hospitalized For Prostate Cancer Treatment
In January 2024, India launched guidelines for hospitals on ICU admissions and directed that hospitals cannot admit critically ill patients to the ICU without the consent of the patient and family.
According to the latest guidelines, patients who are critically ill should not be admitted to an ICU if they do not give their consent.
"Critically ill patients should not be admitted to the ICU; if the patient or next-of-kin informed refusal to be admitted in ICU."
Credit: NASA
Nearly 60 years after humanity first set foot on the Moon, NASA has launched its historic Artemis II mission, marking the first crewed journey around the lunar surface.
The nearly 10-day flight was launched successfully on April 1 from the Kennedy Space Center (KSC) in Florida at 6:24 p.m. EDT.
Four astronauts were launched to the surface of the Moon aboard Orion, which lifted off atop NASA's Space Launch System.
The Orion spacecraft flight carries NASA astronauts Reid Wiseman, Victor Glover, and Christina Koch, along with Canadian Space Agency astronaut Jeremy Hansen.
The crew aims to loop around the moon and return to Earth on a free-return trajectory, reaching roughly 4,700 miles (7,560 kilometers) beyond the moon's far side — farther than Apollo 8's historic lunar flyby and the most distant journey ever attempted by humans.
During the 10-day journey, the four astronauts will also perform several science experiments, along with scientists on Earth, to facilitate science investigations to inform future human spaceflight missions.
NASA stated that the Artemis II science operations will lay the foundation for safe and efficient human exploration of the Moon and Mars.
The study will evaluate how crew members perform individually and as a team throughout the mission, including how easily they can move around within the confined space of their Orion spacecraft.
Scientists will analyze blood and saliva samples from Artemis II crew members to see how deep space changes the immune system.
Crews are supplying a consistent set of health information to a data bank so that future researchers can learn more about astronaut health.
Equipment will monitor radiation levels inside and outside the Orion capsule to help characterize the deep space environment.

“The findings are expected to provide vital insights for future missions to destinations beyond low Earth orbit, including Mars,” said Laurie Abadie, an aerospace engineer for the program at NASA’s Johnson Space Center in Houston.
“The lessons we learn from this crew will help us to more safely accomplish deep space missions and research,” she said.
Steven Platts, chief scientist for human research at NASA Johnson, explained the mission will need to protect against challenges, including exposure to higher radiation levels than on the International Space Station, since the crew will be farther from Earth.
“Together, these studies will allow scientists to better understand how the immune system performs in deep space, teach us more about astronauts’ overall well-being ahead of a Mars mission, and help scientists develop ways to ensure the health and success of crew members,” he said.
Credit: Canva
The emerging COVID-19 BA.3.2 variant, dubbed Cicada and detected in 23 countries, may not pose a significant global threat, claimed a study.
The 2025 study, published in the mBio journal, showed that the immune response of the BA 3.2 COVID variant from vaccines or prior infection is less effective than against the original strain. The antibody effectiveness is three times lower against the BA.3.2 variant. However, it does not mean that there is no protection at all.
“BA.3.2 showed intermediate neutralization, representing a 3-fold reduction compared to the ancestral strain,” said the researchers from the Icahn School of Medicine at Mount Sinai, US.
“BA.3.2 occupied an intermediate but distinctly separate position,” they said, adding that the variant “shows substantial immune escape potential that threatens protection”.
In the study, the researchers used antigenic mapping to assess neutralizing antibody responses in 56 adults with varied exposure histories following KP.2 vaccination against emerging variants, including LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2.
While KP.2 vaccination enhanced neutralization against homologous variants, substantial reductions in neutralizing activity were observed against emerging Omicron variants across all exposure groups.
Exposure history showed some influence on neutralization breadth, with self-reported vaccination-only participants exhibiting better cross-neutralization compared to individuals with hybrid immunity.
The findings highlight the ongoing challenge of maintaining vaccine effectiveness against evolving SARS-CoV-2 variants and argue for continuous updating of vaccines, the researchers said.
“Despite its extraordinary number of mutations, BA.3.2 is not able to overcome immunity from vaccination, finds study. Other variants were more capable of evading immunity. This indicates it is not a major real-world threat,” said Dr Rajeev Jayadevan, Ex-President of IMA Cochin and Convener of the Research Cell, Kerala, in a post on social media platform X. He was not part of the study.
BA.3.2 is a descendant of the Omicron BA.3 lineage. It is genetically distinct from the previously circulating JN.1 lineages (including LP.8.1 and XFG).
BA.3.2 comprises two major branches, BA.3.2.1 and BA.3.2.2. BA.3.2.2 also has substitutions like: K356T, A575S, R681H, and R1162P, the CDC report said.
What makes the BA.3.2 variant special is the “70 to 75 substitutions and deletions in the gene sequence of its spike protein”, according to the US CDC’s latest Morbidity and Mortality Weekly Report.
“BA.3.2 represents a new lineage of SARS-CoV-2, genetically distinct from the JN.1 lineages (including LP.8.1 and XFG) that have circulated in the US since January 2024,” said the CDC researchers.
“BA.3.2 mutations in the spike protein have the potential to reduce protection from a previous infection or vaccination,” they added.
However, the new Cicada variant with around 75 genetic changes in its spike protein is likely to disproportionately affect children, as per an expert, who noted its presence in the UK.
“Some people have done analysis on this, suggesting it may be more prevalent among young children. Children get infections all the time, but this might be something to do with the fact that they have never been exposed to Covid vaccines," Prof Ravindra Gupta, of Cambridge University, who advised the UK government during the pandemic, was quoted as saying to The Mirror.
“So this is something we’re looking at in the lab to try and work out why. The problem with this is that it is an infection that spreads fast. Eventually, it ends up in someone vulnerable," he added.
Symptoms seem to be similar to those of other recent variants and include
sore throat,
cough,
congestion,
fatigue,
headache
fever.
According to the CDC, the Cicada variant is also likely to raise gastrointestinal issues such as nausea or diarrhea.
© 2024 Bennett, Coleman & Company Limited